What is AccuVein?
AccuVein Inc. stands as the global leader in vein visualization technology, offering a unique hand-held, non-contact solution that projects a map of peripheral veins directly onto the skin's surface. This proprietary technology, recognized with accolades such as the Prism Award for Photonics Innovation, aids healthcare professionals in accurately accessing or avoiding veins during procedures. Deployed in over 4,000 facilities and available in more than 120 countries, AccuVein's innovation is built upon a robust and expanding patent portfolio covering a wide array of imaging and medical diagnostic technologies.
How much funding has AccuVein raised?
AccuVein has raised a total of $37.9M across 5 funding rounds:
Series B
$22.5M
Debt
$8M
Debt
$2.5M
Debt
$2.9M
Debt
$2M
Series B (2011): $22.5M with participation from Bessemer Venture Partners and MVM Life Science Partners
Debt (2014): $8M led by Horizon Technology Finance Corporation
Debt (2016): $2.5M, investors not publicly disclosed
Debt (2017): $2.9M, investors not publicly disclosed
Debt (2020): $2M backed by PPP
Key Investors in AccuVein
Bessemer Venture Partners
Bessemer Venture Partners is a venture capital firm established in 1911, with a global presence and a focus on early-stage investments across various technology sectors. Their involvement suggests a belief in AccuVein's long-term growth potential and innovative technology.
MVM Life Science Partners
MVM Partners LLP is a venture capital firm specializing in innovative healthcare companies, actively supporting businesses that enhance healthcare delivery through quality and cost-effective solutions. Their investment in AccuVein highlights a focus on medical technology that improves patient outcomes.
Horizon Technology Finance Corporation
Horizon Technology Finance Corporation is a specialty finance company providing structured debt financing to development-stage companies, particularly in technology and life sciences. Their participation indicates AccuVein's strong financial footing and potential for significant returns.
What's next for AccuVein?
The substantial enterprise-level funding and recent strategic investment signal AccuVein's readiness for accelerated expansion and further technological development. This capital infusion is likely to fuel advancements in its vein visualization platform, potentially broadening its applications within healthcare settings and enhancing its global reach. Strategic partnerships and continued innovation will be key as AccuVein aims to solidify its leadership in medical imaging and diagnostic solutions, addressing critical needs in patient care and procedural efficiency.
See full AccuVein company page
